
Sign up to save your podcasts
Or


Though currently littered with penny stocks, the landscape for investing in marijuana is improving. Shannon Jones analyzes the recent merger of Aurora Cannabis and MedReleaf, and the impending FDA approval for GW Pharmaceuticals. Plus, we discuss how professional athletes and owners are helping the case by becoming more vocal about marijuana as a device for pain management.
By The Motley Fool4.7
16041,604 ratings
Though currently littered with penny stocks, the landscape for investing in marijuana is improving. Shannon Jones analyzes the recent merger of Aurora Cannabis and MedReleaf, and the impending FDA approval for GW Pharmaceuticals. Plus, we discuss how professional athletes and owners are helping the case by becoming more vocal about marijuana as a device for pain management.

3,220 Listeners

1,489 Listeners

807 Listeners

945 Listeners

523 Listeners

1,166 Listeners

2,184 Listeners

825 Listeners

1,423 Listeners

1,038 Listeners

9,718 Listeners

196 Listeners

827 Listeners

87 Listeners

589 Listeners

1,028 Listeners

53 Listeners